20/05/2024  22:10:00 Chg. +0.33 Volume Bid02:00:00 Demandez à02:00:00 Capitalisation boursière Dividende Y. Rapport P/E
174.39USD +0.19% 2.25 Mio.
Chiffrre d'affaires: 195.86 Mio.
170.07Bid taille: 200 175.00Ask la taille: 200 79.57 Mrd.USD 0.89% 34.33

Description de l'entreprise

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.
 

Conseil d'administration & Conseil de surveillance

PDG
Kristin Peck
Conseil d'administration
Wetteny Joseph, Nick Ashton, Jamie Brannan, Heidi Chen, Rimma Driscoll, Jeannette Ferran Astorga, Roxanne Lagano, Wafaa Mamilli, Robert Polzer
Conseil de surveillance
Michael McCallister, Paul M. Bisaro, Vanessa Broadhurst, Frank D’Amelio, Sanjay Khosla, Antoinette R. Leatherberry, Gregory Norden, Louise M. Parent, Kristin Peck, Dr. Willie M. Reed, Dr. Linda Rhodes, Robert Scully
 

Données de l'entreprise

Nom: Zoetis Inc.
Adresse: 10 Sylvan Way,Parsippany, New Jersey 07054, USA
Téléphone: +1-973-822-7000
Fax: -
Courriel: -
Internet: www.zoetis.com/
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 83.54%
IPO date: 01/02/2013

Relations avec les investisseurs

Nom: Steve Frank
Téléphone IR: +1-973-822-7141
IR-Fax: -
E-mail IR: steve.frank@zoetis.com

Calendrier de l'entreprise

CW 23 | 04/06/2024 Dividend Payment